34712130|t|Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer's Disease.
34712130|a|Alzheimer's disease (AD), the most common neurodegenerative disease in elderly humans, is pathologically characterized by amyloid plaques and neurofibrillary tangles. Mitochondrial dysfunction that occurs in the early stages of AD, which includes dysfunction in mitochondrial generation and energy metabolism, is considered to be closely associated with AD pathology. Selenomethionine (Se-Met) has been reported to improve cognitive impairment and reduce amyloid plaques and neurofibrillary tangles in 3xTg-AD mice. Whether Se-Met can regulate mitochondrial dysfunction in an AD model during this process remains unknown.In this study, the N2a-APP695-Swedish (N2aSW) cell and 8-month-old 3xTg-AD mice were treated with Se-Met in vitro and in vivo. Our study showed that the numbers of mitochondria were increased after treatment with Se-Met. Se-Met treatment also significantly increased the levels of NRF1 and Mfn2, and decreased those of OPA1 and Drp1. In addition, the mitochondrial membrane potential was significantly increased, while the ROS levels and apoptosis rate were significantly decreased, in cells after treatment with Se-Met. The levels of ATP, complex IV, and Cyt c and the activity of complex V were all significantly increased. Furthermore, the expression level of SELENO O was increased after Se-Met treatment. Thus, Se-Met can maintain mitochondrial dynamic balance, promote mitochondrial fusion or division, restore mitochondrial membrane potential, promote mitochondrial energy metabolism, inhibit intracellular ROS generation, and reduce apoptosis. These effects are most likely mediated via upregulation of SELENO O. In summary, Se-Met improves mitochondrial function by upregulating mitochondrial selenoprotein in these AD models.
34712130	0	16	Selenomethionine	Chemical	MESH:D012645
34712130	26	39	Mitochondrial	Disease	MESH:D028361
34712130	65	78	Mitochondrial	Disease	MESH:D028361
34712130	79	92	Selenoprotein	Gene	93684
34712130	107	126	Alzheimer's Disease	Disease	MESH:D000544
34712130	128	147	Alzheimer's disease	Disease	MESH:D000544
34712130	149	151	AD	Disease	MESH:D000544
34712130	170	195	neurodegenerative disease	Disease	MESH:D019636
34712130	207	213	humans	Species	9606
34712130	250	265	amyloid plaques	Disease	MESH:D058225
34712130	270	293	neurofibrillary tangles	Disease	MESH:D055956
34712130	295	320	Mitochondrial dysfunction	Disease	MESH:D028361
34712130	356	358	AD	Disease	MESH:D000544
34712130	390	403	mitochondrial	Disease	MESH:D028361
34712130	482	484	AD	Disease	MESH:D000544
34712130	496	512	Selenomethionine	Chemical	MESH:D012645
34712130	514	520	Se-Met	Chemical	MESH:D012645
34712130	551	571	cognitive impairment	Disease	MESH:D003072
34712130	583	598	amyloid plaques	Disease	MESH:D058225
34712130	603	626	neurofibrillary tangles	Disease	MESH:D055956
34712130	630	635	3xTg-	CellLine	CVCL:C6V6
34712130	635	637	AD	Disease	MESH:D000544
34712130	638	642	mice	Species	10090
34712130	652	658	Se-Met	Chemical	MESH:D012645
34712130	672	697	mitochondrial dysfunction	Disease	MESH:D028361
34712130	704	706	AD	Disease	MESH:D000544
34712130	768	779	N2a-APP695-	CellLine	CVCL:XZ52
34712130	788	793	N2aSW	CellLine	CVCL:XZ53
34712130	816	820	3xTg	Disease	
34712130	821	823	AD	Disease	MESH:D000544
34712130	824	828	mice	Species	10090
34712130	847	853	Se-Met	Chemical	MESH:D012645
34712130	962	968	Se-Met	Chemical	MESH:D012645
34712130	970	976	Se-Met	Chemical	MESH:D012645
34712130	1030	1034	NRF1	Gene	18181
34712130	1039	1043	Mfn2	Gene	170731
34712130	1068	1072	OPA1	Gene	74143
34712130	1077	1081	Drp1	Gene	12933
34712130	1100	1113	mitochondrial	Disease	MESH:D028361
34712130	1172	1175	ROS	Chemical	-
34712130	1262	1268	Se-Met	Chemical	MESH:D012645
34712130	1284	1287	ATP	Chemical	MESH:D000255
34712130	1412	1420	SELENO O	Gene	223776
34712130	1441	1447	Se-Met	Chemical	MESH:D012645
34712130	1465	1471	Se-Met	Chemical	MESH:D012645
34712130	1485	1498	mitochondrial	Disease	MESH:D028361
34712130	1524	1537	mitochondrial	Disease	MESH:D028361
34712130	1566	1579	mitochondrial	Disease	MESH:D028361
34712130	1608	1621	mitochondrial	Disease	MESH:D028361
34712130	1663	1666	ROS	Chemical	-
34712130	1760	1769	SELENO O.	Gene	223776
34712130	1782	1788	Se-Met	Chemical	MESH:D012645
34712130	1798	1811	mitochondrial	Disease	MESH:D028361
34712130	1837	1850	mitochondrial	Disease	MESH:D028361
34712130	1851	1864	selenoprotein	Gene	93684
34712130	1874	1876	AD	Disease	MESH:D000544
34712130	Positive_Correlation	MESH:D000255	MESH:D012645
34712130	Negative_Correlation	MESH:D012645	MESH:D000544
34712130	Positive_Correlation	MESH:D012645	18181
34712130	Positive_Correlation	MESH:D012645	MESH:D028361
34712130	Negative_Correlation	MESH:D012645	74143
34712130	Association	MESH:D000544	93684
34712130	Positive_Correlation	MESH:D012645	223776
34712130	Association	MESH:D028361	93684
34712130	Positive_Correlation	MESH:D012645	170731
34712130	Negative_Correlation	MESH:D012645	MESH:D055956
34712130	Positive_Correlation	MESH:D012645	93684
34712130	Negative_Correlation	MESH:D012645	12933
34712130	Negative_Correlation	MESH:D012645	MESH:D003072
34712130	Negative_Correlation	MESH:D012645	MESH:D058225
34712130	Association	MESH:D028361	223776

